gatifloxacin has been researched along with Central Nervous System Diseases in 2 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study showed that the treatment of respiratory tract infections with gatifloxacin was safe and efficient and had a low incidence of adverse events." | 6.70 | Treatment of adults with community-acquired respiratory tract infections: results of a multicentric clinical trial with gatifloxacin. ( Medeiros, EA, 2002) |
| "This study showed that the treatment of respiratory tract infections with gatifloxacin was safe and efficient and had a low incidence of adverse events." | 2.70 | Treatment of adults with community-acquired respiratory tract infections: results of a multicentric clinical trial with gatifloxacin. ( Medeiros, EA, 2002) |
| " The incidence of adverse events was low and the most commonly reported events were nausea and dyspepsia." | 2.70 | Effectiveness, safety and tolerability of gatifloxacin, a new 8-methoxyfluoroquinolone, in the treatment of outpatients with community-acquired pneumonia: a Brazilian study. ( Carvalho, CR; Franca, SA, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Medeiros, EA | 1 |
| Franca, SA | 1 |
| Carvalho, CR | 1 |
2 trials available for gatifloxacin and Central Nervous System Diseases
| Article | Year |
|---|---|
Treatment of adults with community-acquired respiratory tract infections: results of a multicentric clinical trial with gatifloxacin.
Topics: Adult; Aged; Anti-Infective Agents; Central Nervous System Diseases; Community-Acquired Infections; | 2002 |
Effectiveness, safety and tolerability of gatifloxacin, a new 8-methoxyfluoroquinolone, in the treatment of outpatients with community-acquired pneumonia: a Brazilian study.
Topics: Adult; Aged; Anti-Infective Agents; Brazil; Central Nervous System Diseases; Community-Acquired Infe | 2002 |